Of note, the HLA-ABC negative cell line OVCAR8 failed to elicit robust IFNγ release in TICS (Fig. 2b) and prime CD8+ T cell activation (data not shown), highlighting the necessity of TCR-HLA engagement for cancer cell recognition. The gene discussed is CD8A; the disease is cancer.